Helen Susan Kim Insider Trading
Get free email notifications about insider trading for Helen Susan Kim.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Helen Susan Kim. Helen Susan Kim is a President and CEO in KOSAN BIOSCIENCES INC ($KOSN) and a President, CBO in KOSAN BIOSCIENCES INC ($KOSN) and a Sr VP, Chief Business Officer in KOSAN BIOSCIENCES INC ($KOSN) and a Director in SUNESIS PHARMACEUTICALS INC ($SNSS) and a Director in ASSEMBLY BIOSCIENCES, INC. ($ASMB) and a EVP, Business Development in Kite Pharma, Inc. ($KITE) and a Director in Max-1 Acquisition Corp ($XCUR) and a Director in Applied Molecular Transport Inc. ($AMTI).
Address: 3832 BAY CENTER PLACE HAYWARD 94545 CA
Companies in which Helen Susan Kim is an Insider
Applied Molecular Transport Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Helen Susan Kim: Director
Holdings: 800,000 shares
Latest Transaction: May 20 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ASSEMBLY BIOSCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Helen Susan Kim: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 15 2020
$ASMB Market Capitalization: $356.73M
$ASMB Previous Close: $20.78
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EXICURE, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Helen Susan Kim: Director
Holdings: 0 shares
Latest Transaction: Jun 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kite Pharma, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Helen Susan Kim: EVP, Business Development
Holdings: 17,500 shares
Current Value: $933,100
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KOSAN BIOSCIENCES INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Helen Susan Kim: President and CEO, President, CBO, Sr VP, Chief Business Officer
Holdings: 0 shares
Latest Transaction: Jun 30 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viracta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Helen Susan Kim: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 01 2015
$SNSS Market Capitalization: $85.18M
$SNSS Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Helen Susan Kim
Sentiment: All, AMTI, ASMB, XCUR, KITE, KOSN, SNSS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2021 | AMTI | Applied Molecular ... | Kim Helen Susan | Director | Option Exercise | A | 47.01 | 14,343 | 674,264 | 14,343 | |
| Jul 06 2020 | AMTI | Applied Molecular ... | Kim Helen Susan | Director | Option Exercise | M | 0.02 | 800,000 | 16,000 | 0 | |
| Jul 06 2020 | AMTI | Applied Molecular ... | Kim Helen Susan | Director | Buy | M | 0.02 | 800,000 | 16,000 | 800,000 | 0 to 800 K |
| Jun 15 2020 | ASMB | ASSEMBLY BIOSCIENC ... | Kim Helen Susan | Director | Option Exercise | A | 20.47 | 10,000 | 204,700 | 10,000 | |
| Jun 08 2020 | XCUR | EXICURE, INC. | Kim Helen Susan | Director | Option Exercise | A | 2.79 | 21,693 | 60,523 | 21,693 | |
| Jun 14 2019 | XCUR | EXICURE, INC. | Kim Helen Susan | Director | Option Exercise | A | 2.78 | 21,693 | 60,307 | 21,693 | |
| May 17 2019 | ASMB | ASSEMBLY BIOSCIENC ... | Kim Helen Susan | Director | Option Exercise | A | 15.22 | 10,000 | 152,200 | 10,000 |